Lundblad D, Landberg G, Roos G, Lundgren E
Institute of Applied Cell and Molecular Biology, University of Umeå, Sweden.
Anticancer Res. 1991 Nov-Dec;11(6):2131-6.
The effects of interferon (IFN) on the expression of the nuclear antigen Ki-67 were studied in the two IFN-sensitive tumour cell lines Daudi and 251 MG, known to be arrested in the cell cycle in separate stages. The GO/G1-arrested Burkitt's lymphoma cell line Daudi displayed an increasing fraction of Ki-67 negative cells with time, concomitant with an increasing proportion of growth arrested cells. A small fraction of Ki-67 positive cells were found mainly arrested in G2/M. In contrast, no effect on Ki-67 expression was seen in IFN-resistant Namalwa cells, nor in the sensitive glioma cell line 251 MG, which is blocked in the S phase of the cell cycle. Agents blocking the cells in other phases of the cycle did not affect Ki-67 expression. However, after serum deprivation, no Ki-67 expression was found in the glioma cell line, while restimulation initiated expression after 12 hours as cells entered the S phase. We conclude that the Ki-67 antigen was not down regulated in all cells inhibited by IFN and thus does not seem to be useful to monitor clinical effects of IFN treatment.
在两种对干扰素(IFN)敏感的肿瘤细胞系Daudi和251 MG中研究了IFN对核抗原Ki-67表达的影响,已知这两种细胞系在细胞周期的不同阶段被阻滞。处于G0/G1期阻滞的伯基特淋巴瘤细胞系Daudi中,随着时间的推移,Ki-67阴性细胞的比例增加,同时生长阻滞细胞的比例也增加。一小部分Ki-67阳性细胞主要阻滞在G2/M期。相比之下,在对IFN耐药的Namalwa细胞以及在细胞周期S期被阻滞的敏感胶质瘤细胞系251 MG中,未观察到对Ki-67表达的影响。在细胞周期其他阶段阻滞细胞的试剂不影响Ki-67表达。然而,血清剥夺后,在胶质瘤细胞系中未发现Ki-67表达,而当细胞进入S期时,再刺激12小时后开始表达。我们得出结论,在所有被IFN抑制的细胞中,Ki-67抗原并未下调,因此似乎无助于监测IFN治疗的临床效果。